|
Israeli regenerative medicine company aims to manufacture cannabinoid-producing cells
[Jpost] Pluristem Therapeutics, best known for developing novel placenta-based cell therapy products, announced May 6 that it has filed a US provisional patent application titled “Methods and Compositions for Producing Cannabinoids,” which covers the use of Pluristem’s state-of-the-art, proprietary 3-D cell culturing technology for the potential manufacturing of cannabinoid-producing cells.Posted by: g(r)omgoru 2019-05-08 |
| http://www.rantburg.com/poparticle.php?ID=540531 |